Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immunologic and virologic response to highly active antiretroviral therapy in the Multicenter AIDS Cohort Study.

AIDS (London, England) - 13 Apr 2001

Yamashita T E, Phair J P, Muñoz A, Margolick J B, Detels R, O'Brien S J, Mellors J W, Wolinsky S M, Jacobson L P

Abstract excerpt

OBJECTIVES: To evaluate prior antiretroviral therapy experience and host characteristics as determinants of immunologic and virologic response to highly active antiretroviral therapy (HAART). METHODS: We studied 397 men from the Multicenter AIDS Cohort Study (MACS) who initiated HAART between October 1995 and March 1999. CD4 cell count and HIV-1 RNA responses to HAART were measured at the first visit following...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acquired Immunodeficiency Syndrome
Share to Antiretroviral Therapy, Highly Active

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to CD4 Lymphocyte Count

Share to Data Interpretation, Statistical

Share to Racial Groups

Share to Receptors, CCR2

Share to Receptors, CCR5

Share to Receptors, Chemokine

Source

Identifiers

PMID: 11371688
DOI: 10.1097/00002030-200104130-00009

Genes

CCR5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immunologic and virologic response to highly active antiretroviral therapy in the Multicenter AIDS Cohort Study.PMID 11371688Read ↗

Treatment history and baseline viral load, but not viral tropism or CCR-5 genotype, influence prolonged antiviral efficacy of highly active antiretroviral treatment.Semantic proximity Read ↗

Host genetic influences on highly active antiretroviral therapy efficacy and AIDS-free survival.Semantic proximity Read ↗

CCR 5 expression, haplotype and immune activation in protection from infection in HIV ‐exposed uninfected individuals in HIV ‐serodiscordant relationshipsSemantic proximity Read ↗

Genetic factors that confer sensitivity to HAART in HIV-infected subjects: implication of a benefit of an earlier initiation of HAART.Semantic proximity Read ↗

CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individuals.Semantic proximity Read ↗

Effect of chemokine receptor gene polymorphisms on the response to potent antiretroviral therapy.Semantic proximity Read ↗

Chemokine (C-C motif) receptor 5 -2459 genotype in patients receiving highly active antiretroviral therapy: race-specific influence on virologic success.Semantic proximity Read ↗

Cellular restoration in HIV infected persons treated with abacavir and a protease inhibitor: age inversely predicts naive CD4 cell count increaseSemantic proximity Read ↗

Sex Differences in HIV RNA Level and CD4 Cell Percentage During ChildhoodSemantic proximity Read ↗

Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.Semantic proximity Read ↗

CCR2-64I and CXCL12 3'A alleles confer a favorable prognosis to AIDS patients undergoing HAART therapy.Semantic proximity Read ↗

Presence of the variant mannose-binding lectin alleles associated with slower progression to AIDS. Amsterdam Cohort Study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.